Actively Recruiting

Phase Not Applicable
Age: 16Years +
All Genders
NCT06013748

Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial

Led by University Medical Center Groningen · Updated on 2025-09-10

112

Participants Needed

3

Research Sites

169 weeks

Total Duration

On this page

Sponsors

U

University Medical Center Groningen

Lead Sponsor

Z

ZonMw: The Netherlands Organisation for Health Research and Development

Collaborating Sponsor

AI-Summary

What this Trial Is About

Rationale: Auditory verbal hallucinations (AVH) - hearing voices that others cannot hear - are common in mental illnesses. For many people AVH are distressing, disabling and persistent, despite medication. Current psychological interventions show low to medium effects. Preliminary studies suggest that an innovative empowering psychological therapy using computer simulations representing the AVH (avatars) can be effective for reducing AVH distress and frequency. Virtual reality (VR) has the potential to improve this treatment. Therefore, we developed a novel VR treatment for this problem. In this study, the effect of this treatment will be investigated. Objective: To test the effect of a novel VR treatment for AVH (VR-VOICES) on distress and frequency of AVH in patients with a psychiatric disorder. Furthermore, to investigate the effect of VR-VOICES on clinical symptoms, quality of life, and healthcare costs of the treatment.

CONDITIONS

Official Title

Virtual Reality Therapy for Voice Hearing (VR-VOICES): a Randomized Controlled Trial

Who Can Participate

Age: 16Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Having a DSM-5 diagnosis of a psychiatric disorder
  • Experiencing distressing auditory verbal hallucinations for at least 3 months
  • Being 16 years of age or older
Not Eligible

You will not qualify if you...

  • Insufficient command of the Dutch language
  • Unable to provide informed consent
  • Primary diagnosis of substance use disorder or organic brain disease such as dementia
  • Substance abuse that interferes with treatment adherence
  • Auditory verbal hallucinations in a language not spoken by therapists
  • Receiving or recently received CBT focused on empowerment over voices within 6 months prior to enrollment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 3 locations

1

Lentis

Groningen, Provincie Groningen, Netherlands

Not Yet Recruiting

2

GGZ Drenthe

Assen, Netherlands

Actively Recruiting

3

University Medical Center Groningen

Groningen, Netherlands, 9712EW

Actively Recruiting

Loading map...

Research Team

C

Chris Geraets, dr

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

SINGLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here